These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 15974483)
21. [A comparative study of the efficacy and safety Zhibitai and atorvastatin]. Xu DY; Shu J; Huang QY; Liu L; Zhao SP Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):392-5. PubMed ID: 20646412 [TBL] [Abstract][Full Text] [Related]
22. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves. Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788 [No Abstract] [Full Text] [Related]
23. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia. Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y Am J Cardiol; 2004 Aug; 94(4):497-500. PubMed ID: 15325939 [TBL] [Abstract][Full Text] [Related]
24. [Atorvastatin in the treatment of patients with hereditary hypercholesterolemia]. Susekov AV; Balakhonova TV; Pogorelova OA; Aligisheeva ZA; Titov VN; At'kov OIu; Kukharchuk VV Kardiologiia; 2003; 43(8):36-9. PubMed ID: 14593381 [TBL] [Abstract][Full Text] [Related]
25. Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin. Nakad A; Bataille L; Hamoir V; Sempoux C; Horsmans Y Lancet; 1999 May; 353(9166):1763-4. PubMed ID: 10347994 [No Abstract] [Full Text] [Related]
26. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Dorea EL; Bernik M; Hirata RD Clin Chim Acta; 2008 Jul; 393(2):119-24. PubMed ID: 18435918 [TBL] [Abstract][Full Text] [Related]
27. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients. Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877 [TBL] [Abstract][Full Text] [Related]
28. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607 [TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia. Poolsup N; Suksomboon N; Wongyaowarat K; Rungkanchananon B; Niyomrat P; Kongsuwan S J Clin Pharm Ther; 2012 Apr; 37(2):166-72. PubMed ID: 21585411 [TBL] [Abstract][Full Text] [Related]
30. Atorvastatin increases blood ratios of vitamin E/low-density lipoprotein cholesterol and coenzyme Q10/low-density lipoprotein cholesterol in hypercholesterolemic patients. Liu CS; Lii CK; Chang LL; Kuo CL; Cheng WL; Su SL; Tsai CW; Chen HW Nutr Res; 2010 Feb; 30(2):118-24. PubMed ID: 20226997 [TBL] [Abstract][Full Text] [Related]
31. A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study. Farsang C; Athyros V; Gaw A; Curr Med Res Opin; 2007 Aug; 23(8):1945-56. PubMed ID: 17626713 [TBL] [Abstract][Full Text] [Related]
32. Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve. Makkena B; Salti H; Subramaniam M; Thennapan S; Bonow RH; Caira F; Bonow RO; Spelsberg TC; Rajamannan NM J Am Coll Cardiol; 2005 Feb; 45(4):631-3. PubMed ID: 15708716 [No Abstract] [Full Text] [Related]
33. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study. Wolffenbuttel BH; Franken AA; Vincent HH; J Intern Med; 2005 Jun; 257(6):531-9. PubMed ID: 15910557 [TBL] [Abstract][Full Text] [Related]
34. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162 [TBL] [Abstract][Full Text] [Related]
35. [Atorvastatin for primary prevention of cardiovascular events. ASCOT-LLA Study]. März W Internist (Berl); 2004 Mar; 45(3):355-7. PubMed ID: 14997313 [No Abstract] [Full Text] [Related]
36. Efficacy and safety of atorvastatin 10 mg every other day in hypercholesterolemia. Piamsomboon C; Laothavorn P; Saguanwong S; Chatlaong B; Nasawadi C; Tanprasert P; Pongsiri K J Med Assoc Thai; 2002 Mar; 85(3):297-300. PubMed ID: 12117017 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [TBL] [Abstract][Full Text] [Related]